EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023

Related Keywords

Milan ,Lombardia ,Italy ,France ,Paris ,France General ,Leuven ,Region Flamande ,Belgium ,Munich ,Bayern ,Germany ,Belgian ,Andera Croissance ,Aneta Sottil ,Bernard Coulie ,Wouter Verhoeven ,Luc Van Rompaey ,Andera Life Sciences ,Wurzburg University ,Mc Services ,Distribution Services ,Ghent University ,Bandera Co ,Andera Partners ,Fountain Healthcare Partners ,Independent Chairman ,V Bio Ventures ,Dualyx Board ,Pliant Therapeutics ,Van Rompaey ,Andera Midcap ,Andera Expansion ,Andera Co Invest ,Andera Acto ,Andera Infra ,Bien Commun Advisory ,Corporate News ,Regulatory Announcements ,Gefallene Big Techs ,News ,Tendera ,Partners ,Heads ,Billion ,Series ,Dualyx ,Biotech ,Developing ,Novel ,Greg ,Therapies ,Autoimmune ,Diseases ,